NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Applied Digital Plans Cloud Spinoff with EKSO to Form ChronoScale - Citizens Maintains $40 Target

Citizens keeps Outperform rating on Applied Digital at $40 as company plans to spin out cloud business with EKSO Bionics, creating dedicated AI compute platform ChronoScale.

Applied Digital Plans Cloud Spinoff with EKSO to Form ChronoScale - Citizens Maintains $40 Target
Credit: EKSO Bionics
Already have an account? Sign in.
12/30/2025 · 5:49 AM
EKSO
/ Read more

Feed↓

CVC Weighs €9bn Bid to Take Italy’s Nexi Private
Featured/ 04/28/2026 · 12:35 PM

CVC Weighs €9bn Bid to Take Italy’s Nexi Private

CVC Capital Partners may buy Nexi for €9B, but faces political hurdles and weak business performance.

/ Subscriber only
Pfizer Delays Generic Vyndamax Until 2031 – Great News for BridgeBio’s Attruby
Featured/ 04/28/2026 · 10:07 AM

Pfizer Delays Generic Vyndamax Until 2031 – Great News for BridgeBio’s Attruby

Pfizer extends Vyndamax patent to 2031, delaying generics and giving BridgeBio more time to grow its rival heart drug without pressure.

/ Subscriber only
Rocket Scores $180 Million Cash Boost – Extends Runway to 2028 for Heart Gene Therapies
04/28/2026 · 9:29 AM

Rocket Scores $180 Million Cash Boost – Extends Runway to 2028 for Heart Gene Therapies

Rocket Pharma sold an FDA voucher for $180M cash, boosting funds without dilution and extending runway to 2028 for heart gene therapies.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe